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by the principle investigator, Dr. G. Cohen, was to examine the ability of monoamine oxidaseassociated substrates such as dopamine and tyramine to inhibit mitochondrial respiration. The studies entailed initially characterizing the ability of the two substrates to inhibit respiration in brain mitochondria, and to subsequently identify and characterize the underlying biochemical mechanisms responsible for the inhibition. Dr. Cohen proposed the possibility that monoamine oxidase (MAO)-derived production of hydrogen peroxide could hypothetically lead to oxidative damage within the mitochondria, and induce mitochondrial dysfunction. In one publication he reported that the inhibition of mitochondrial respiration by MAO substrates was associated with significant increases in levels of glutathione-protein-mixed disulfides, and that covalent modification of protein thiols by glutathione could inactivate critical thiol-dependent proteins within the electron transport chain (Cohen and Kessler, 1999 [Dopamine]
Figure; 1. Rat brain niitochondria were treated with varying concentrations of dopamine + pargyline/chlogyline (4 pM final conc.) for 15 min at 30C, % inhibition of respiration by dopamine is reported as mean ± SD. n is from separate determinations from three mitochondrial preparations. It can be readily observed that millimolar concentrations of dopamine (1c50 = 16.5 mM + 5.6, n-3) are required to inhibit pynuvatehnalate-stimulated respiration in well-coupled mitochondria (RCRs Ž 8). At dopamine concentrations producing less than 25%-30% inhibition there is nearly complete reversibility in the presence of MAO inhibitors. At dopamine concentrations producing greater than 30% inhibition ([DA] > 7mM) there is a minor but significant component of the inhibition which is not reversible in the presence of MAO inhibitors. demonstrate that exposure to DA or H 2 0 2 leads to respiratory inhibition, but no such effect is seen with GSSG. Table 3 shows that upon the separate addition of 1mM GSSG there are corresponding elevations of Pr-S-S-G. The largest increase was observed with 1mM GSSG preincubations (3-4-fold increases in both the matrix space and intermembrane fractions), however, these increases did not correlate with any measurable inhibition of respiration. To further confirm that the lack of inhibition by GSSG was due to inadequate formation of Pr-S-S-G within the ETC we exposed GSSG to freeze-thawed lysed mitochondria, where the ETC can come in direct contact with the GSSG. As with mitochondria, no observable inhibition of any ETC complex was measured in the presence of very high concentrations of GSSG.
These results indicate that the origin of respiratory inhibition by DA is unlikely a result of increased

Pr-S-S-G formation within the ETC due to GSSG formation following MAO-mediated
oxidation ofDA .
In contrast to GSSG exposure, H 2 0 2 exposure leads to significant inhibition of respiration in intact brain mitochondria (Table 2 and Rat brain mitochondria were isolated as described in Methods and incubated with either dopamine (DA), H 2 0 2 or oxidized glutathione (GSSG) at the above indicated concentrations for 30 min at 30°C. At the end of incubation, mitochondria were analyzed for glutathione-protein-mixed disulfide formation. In separate incubations, from the same preparations, mitochondria were exposed to the above compounds using incubation conditions as described in the legends to Figs 2 and 3 and the effects on pyruvate/glutamate/malate supported respiration was determined. 'Different from control, p < 0.05. 0 C and the rate of 02 consumption for pyruvate/malate-or succinate-supported respiration consumption using different substrates to support respiration was (intact), or NADH oxidase or succinate oxidase activities (freezedetermined. IC50 were calculated from nonlinear regression plots thawed or ETPs) were determined as described in Methods. n is from (GraphPad, Inplot). n is from three to five dose-response determinathree to four determinations per dose-response for intact and freezetions per substrate. (b) Intact mitochondria, freeze-thawed mitothawed mitochondria and two for ETPs. chondria or electron transport particles (ETPs) were exposed to Gluck desferroxamine was co-administered with the H 2 0 2 in freeze-thawed lysed mitochondria (Figure 3) . Desferroxamine was able to significantly attenuate the inhibitory effects of H 2 0 2 indicating that HO is likely to be responsible in part for the underlying respiratory inhibition.
Similar studies could not be performed in intact mitochondria because desferroxamine does not diffuse across the IMM into the matrix. 2) With the initial 30%-35% inhibition of mitochondrial respiration cessation of respiration derives exclusively from MAO-associated metabolism of dopamine. At greater than 35% inhibition the inhibition becomes partially independent of MAO activity. These findings suggest that dopamine is capable of inhibiting respiration by MAO-dependent and MAO-independent mechanisms. However, the two pathways may have the common feature of generating reactive oxygen species leading to oxidative damage of the mitochondria.
3) Dopamine is significantly more toxic to respiratory function when it diffuses across the inner mitochondrial membrane into the matrix space. Dopamine is capable of inhibiting Complex I and
Complex II activities in freeze-thawed mitochondria, and is nearly 100-fold more potent than in intact mitochondria. These findings demonstrate that conditions that increase the permeability of dopamine across the inner mitochondrial membrane can lead to significant potentiation of inhibition.
Gluck
Furthermore, dopamine can inhibit electron transport chain function in the absence of MAOmediated oxidation. Our findings suggest that dopamine is capable of inducing mitochondrial dysfunction through enzymatic and non-enzymatic mediated pathways, although both are appear to involve induction of oxidative stress. These findings suggest an ongoing role for antioxidant therapy or inhibition of MAO as a therapeutic intervention for the treatment of Parkinson's Disease, or from protection from neurotoxic substrates metabolized by MAO in the central nervous system, such as agents that our armed forces may be exposed to.
